Prognostic performance of the albumin–gluteus medius index for one-year mortality in geriatric hip fracture patients: a retrospective cohort study

Proximal femur fractures are associated with high mortality in older adults, and accurate prognostic assessment is clinically important. The Albumin–Gluteus Medius Index (AGMI) is a novel composite index integrating CT-derived muscle reserve with serum albumin, an inflammatory and metabolic prognostic biomarker. This study aimed to evaluate the prognostic performance of AGMI in predicting one-year mortality in geriatric patients with hip fracture and to compare its discriminative ability with serum albumin and gluteus medius muscle area individually. This retrospective study included 219 patients aged ≥ 65 years who were treated for hip fracture between January 2021 and May 2025. Gluteus medius muscle area was measured from pelvic CT, and serum albumin levels were recorded. AGMI was calculated as the product of albumin (g/L) and muscle area (mm²). Independent predictors of mortality were assessed using multivariable logistic regression. Discriminative performance was evaluated using receiver operating characteristic (ROC) curve analysis. The one-year mortality rate was 14.6%. AGMI was significantly lower in non-survivors than in survivors ( p < 0.001). In multivariable analysis, age ( p = 0.011), male sex ( p = 0.046), and AGMI were independently associated with one-year mortality. Each 1,000-unit increase in AGMI was associated with a 3% reduction in the odds of mortality (OR 0.97, 95% CI 0.96–0.98; p < 0.001). Among the individual markers, AGMI had the highest observed AUC (0.762, 95% CI 0.676–0.849); however, paired DeLong comparisons with serum albumin and gluteus medius muscle area were not statistically significant. AGMI was independently associated with one-year mortality and had the numerically highest discrimination among the individual markers evaluated. If externally validated, this accessible composite biomarker may serve as an adjunctive tool for early risk stratification in geriatric patients with hip fracture.

Authors

Institutions

Publication Details

Journal
BMC Musculoskeletal Disorders
Published
2026-09-09
DOI
https://doi.org/10.1186/s12891-026-10390-2
Primary Topic
Hip and Femur Fractures
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic performance of the albumin–gluteus medius index for one-year mortality in geriatric hip fracture patients: a retrospective cohort study

İskender Ekinci, İrem Kıraç Utku, Yuksel Topkaya, Sinan Aktürk
BMC Musculoskeletal Disorders
Hip and Femur Fractures
article

Prognostic performance of the albumin–gluteus medius index for one-year mortality in geriatric hip fracture patients: a retrospective cohort study

İskender Ekinci, İrem Kıraç Utku, Yuksel Topkaya, Sinan Aktürk
article en

Abstract

Proximal femur fractures are associated with high mortality in older adults, and accurate prognostic assessment is clinically important. The Albumin–Gluteus Medius Index (AGMI) is a novel composite index integrating CT-derived muscle reserve with serum albumin, an inflammatory and metabolic prognostic biomarker. This study aimed to evaluate the prognostic performance of AGMI in predicting one-year mortality in geriatric patients with hip fracture and to compare its discriminative ability with serum albumin and gluteus medius muscle area individually. This retrospective study included 219 patients aged ≥ 65 years who were treated for hip fracture between January 2021 and May 2025. Gluteus medius muscle area was measured from pelvic CT, and serum albumin levels were recorded. AGMI was calculated as the product of albumin (g/L) and muscle area (mm²). Independent predictors of mortality were assessed using multivariable logistic regression. Discriminative performance was evaluated using receiver operating characteristic (ROC) curve analysis. The one-year mortality rate was 14.6%. AGMI was significantly lower in non-survivors than in survivors ( p < 0.001). In multivariable analysis, age ( p = 0.011), male sex ( p = 0.046), and AGMI were independently associated with one-year mortality. Each 1,000-unit increase in AGMI was associated with a 3% reduction in the odds of mortality (OR 0.97, 95% CI 0.96–0.98; p < 0.001). Among the individual markers, AGMI had the highest observed AUC (0.762, 95% CI 0.676–0.849); however, paired DeLong comparisons with serum albumin and gluteus medius muscle area were not statistically significant. AGMI was independently associated with one-year mortality and had the numerically highest discrimination among the individual markers evaluated. If externally validated, this accessible composite biomarker may serve as an adjunctive tool for early risk stratification in geriatric patients with hip fracture.

BMC Musculoskeletal Disorders
Tekirdağ Namık Kemal University (TR), Bezmiâlem Vakıf Üniversitesi (TR), Setas (Turkey) (TR)
Reduced inequalities
Openalex Percentile: Top 8%
Hip and Femur Fractures
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.